Who Paid My Doc
Exercise capacity study in HFpEF
Research payments
$1,521,041
Through program year 2024, $1,521,041 in research payments was reported against Exercise capacity study in HFpEF, across 232 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Pharma GmbH & Co.KG; Boehringer Ingelheim Canada Ltd.Ltee
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $6,500 | 1 |
| 2020 | Research | $342,653 | 39 |
| 2019 | Research | $1,171,887 | 192 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Bhola Rama Marion, OH Named on 9 payments
- Noel Bedwell Mobile, AL Named on 8 payments
- Matthew Budoff Torrance, CA Named on 8 payments
- Lokesh Chandra Chicago, IL Named on 8 payments
- Pedro Martinez-Clark Miami, FL Named on 6 payments
- Modele Ogunniyi Atlanta, GA Named on 5 payments
- Charles Lovell Norfolk, VA Named on 5 payments
- Todd Lewis St Augustine, FL Named on 5 payments
- Felix Sogade Macon, GA Named on 4 payments
- Matthew Janik Wilmington, NC Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.